# Post-marketing Clinical Observation of an Inactivated Influenza Split Vaccine

> **NCT01568788** · NA · COMPLETED · sponsor: **Hualan Biological Engineering, Inc.** · enrollment: 600 (actual)

## Conditions studied

- Human Influenza

## Interventions

- **BIOLOGICAL:** Inactivated Influenza Vaccine
- **BIOLOGICAL:** Inactivated Influenza Vaccine of Pasteur
- **BIOLOGICAL:** Inactivated Influenza Vaccine of GSK

## Key facts

- **NCT ID:** NCT01568788
- **Lead sponsor:** Hualan Biological Engineering, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2009-01
- **Final completion:** 2009-03
- **Target enrollment:** 600 (ACTUAL)
- **Last updated:** 2012-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01568788

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01568788, "Post-marketing Clinical Observation of an Inactivated Influenza Split Vaccine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01568788. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*